Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Dongwen Zhou
Introduction
Dongwen Zhou is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic antibodies. With a total of 2 patents to his name, Zhou's work is paving the way for advancements in medical treatments.
Latest Patents
Zhou's latest patents focus on the therapeutic use of antibodies against ENPP3. The first patent discloses monoclonal antibodies against ENPP3, bispecific antibodies against ENPP3 and CD3, as well as nucleic acids that encode these antibodies. It also includes vectors and host cells that incorporate these nucleic acids. Additionally, the patent outlines pharmaceutical compositions and conjugates that utilize these antibodies, along with therapeutic methods for their application. The second patent reiterates similar findings, emphasizing the importance of these antibodies in therapeutic contexts.
Career Highlights
Dongwen Zhou is currently associated with Zhejiang Shimai Pharmaceutical Co., Ltd. His work at this company has been instrumental in advancing the research and development of innovative pharmaceutical solutions. Zhou's expertise in antibody technology has positioned him as a key figure in the industry.
Collaborations
Zhou collaborates with notable colleagues, including Zuoxiang Xiao and Jiaping Peng. Their combined efforts contribute to the ongoing research and development initiatives within their organization.
Conclusion
Dongwen Zhou's innovative work in the field of therapeutic antibodies showcases his commitment to advancing medical science. His patents reflect a deep understanding of antibody technology and its potential applications in healthcare.